Prophylactic hyperthermic intraperitoneal chemotherapy may benefit the long-term survival of patients after radical gastric cancer surgery

Hyperthermic intraperitoneal chemotherapy (HIPEC) has been proven to improve the survival rate of gastric cancer and reduce peritoneal recurrence. We aimed to evaluate the effectiveness and safety of prophylactic HIPEC after radical gastric cancer surgery in this study. Researchers searched for stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Xuhui, He, Yuewen, Ma, Wuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850581/
https://www.ncbi.nlm.nih.gov/pubmed/35173230
http://dx.doi.org/10.1038/s41598-022-06417-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850581/
https://www.ncbi.nlm.nih.gov/pubmed/35173230
http://dx.doi.org/10.1038/s41598-022-06417-y

Ejemplares similares